STALNECKER SUSAN M has filed 31 insider transactions across 2 companies since May 2023.
Most recent transaction: a option exercise of 26493 shares of Bioventus Inc. ($BVS) on June 02, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 2, 2025 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Class A Common Stock | 26493 | $0.00 | 105,957.0000 | 64,547,474 | 33.34% | 0.04% |
| June 2, 2025 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Restricted Stock Units | 26493 | $0.00 | 0.0000 | 64,547,474 | 100.00% | 0.04% |
| June 3, 2025 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | A | Restricted Stock Units | 32282 | $0.00 | 32,282.0000 | 64,547,474 | 9999.99% | 0.05% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 1769 | $0.00 | 0.0000 | 136,000,000 | 100.00% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 4070 | $63.08 | 19,730.0000 | 136,000,000 | 25.99% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 3345 | $75.02 | 23,075.0000 | 136,000,000 | 16.95% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 2123 | $103.90 | 25,198.0000 | 136,000,000 | 9.20% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 1769 | $104.06 | 26,967.0000 | 136,000,000 | 7.02% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 2296 | $79.45 | 29,263.0000 | 136,000,000 | 8.51% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | F | Common Stock | 8278 | $132.26 | 20,985.0000 | 136,000,000 | 28.29% | 0.01% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 4070 | $0.00 | 0.0000 | 136,000,000 | 100.00% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 3345 | $0.00 | 0.0000 | 136,000,000 | 100.00% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 2123 | $0.00 | 0.0000 | 136,000,000 | 100.00% | 0.00% |
| Feb. 18, 2025 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 2296 | $0.00 | 0.0000 | 136,000,000 | 100.00% | 0.00% |
| June 11, 2024 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | A | Restricted Stock Units | 26493 | $0.00 | 26,493.0000 | 62,647,554 | 9999.99% | 0.04% |
| June 7, 2024 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Restricted Stock Units | 30400 | $0.00 | 0.0000 | 62,647,554 | 100.00% | 0.05% |
| June 7, 2024 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Class A Common Stock | 30400 | $0.00 | 79,464.0000 | 62,647,554 | 61.96% | 0.05% |
| May 3, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | A | Stock Option (Right to Buy) | 1179 | $0.00 | 1,179.0000 | 138,000,000 | 9999.99% | 0.00% |
| May 3, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | A | Common Stock | 912 | $0.00 | 15,660.0000 | 138,000,000 | 6.18% | 0.00% |
| May 2, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 4788 | $52.70 | 19,536.0000 | 138,000,000 | 32.47% | 0.00% |
| May 2, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | F | Common Stock | 1774 | $142.19 | 17,762.0000 | 138,000,000 | 9.08% | 0.00% |
| May 2, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | S | Common Stock | 3014 | $141.97 | 14,748.0000 | 138,000,000 | 16.97% | 0.00% |
| May 2, 2024 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 4788 | $0.00 | 0.0000 | 138,000,000 | 100.00% | 0.00% |
| June 6, 2023 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Class A Common Stock | 16648 | $0.00 | 49,064.0000 | 61,389,107 | 51.36% | 0.03% |
| June 7, 2023 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | A | Restricted Stock Units | 30400 | $0.00 | 30,400.0000 | 61,389,107 | 9999.99% | 0.05% |
| June 6, 2023 | Bioventus Inc. | $BVS | STALNECKER SUSAN M | Director | M | Restricted Stock Units | 16648 | $0.00 | 0.0000 | 61,389,107 | 100.00% | 0.03% |
| May 12, 2023 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | F | Common Stock | 2634 | $78.27 | 14,748.0000 | 138,000,000 | 15.15% | 0.00% |
| May 12, 2023 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Stock Option (Right to Buy) | 5193 | $0.00 | 0.0000 | 138,000,000 | 100.00% | 0.00% |
| May 12, 2023 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | M | Common Stock | 5193 | $39.70 | 17,382.0000 | 138,000,000 | 42.60% | 0.00% |
| May 5, 2023 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | A | Common Stock | 1574 | $0.00 | 12,189.0000 | 138,000,000 | 14.83% | 0.00% |
| May 5, 2023 | Leidos Holdings, Inc. | $LDOS | STALNECKER SUSAN M | Director | A | Stock Option (Right to Buy) | 2296 | $0.00 | 4,065.0000 | 138,000,000 | 129.79% | 0.00% |